beta-hydroxyisovaleric acid has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, K; Imai, H; Matsuhashi, N; Nonaka, K; Okumura, N; Osada, S; Sasaki, Y; Takahashi, T; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yawata, K; Yoshida, K | 1 |
1 other study(ies) available for beta-hydroxyisovaleric acid and Lung Neoplasms
| Article | Year |
|---|---|
A case report on efficacy of Abound™ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer.
Topics: Aged; Antibodies, Monoclonal; Colonic Neoplasms; Dipeptides; ErbB Receptors; Humans; Lung Neoplasms; Male; Panitumumab; Prognosis; Skin Diseases; Valerates | 2014 |